CN1234401C - 双蚁祛湿通络胶囊 - Google Patents
双蚁祛湿通络胶囊 Download PDFInfo
- Publication number
- CN1234401C CN1234401C CNB2004100127206A CN200410012720A CN1234401C CN 1234401 C CN1234401 C CN 1234401C CN B2004100127206 A CNB2004100127206 A CN B2004100127206A CN 200410012720 A CN200410012720 A CN 200410012720A CN 1234401 C CN1234401 C CN 1234401C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- ant
- blood
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 23
- 241000866536 Odontotermes formosanus Species 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 39
- 241001251068 Formica fusca Species 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 15
- 241000208340 Araliaceae Species 0.000 claims description 13
- 241000903946 Clematidis Species 0.000 claims description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 13
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 235000019634 flavors Nutrition 0.000 claims description 13
- 235000008434 ginseng Nutrition 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 241000131808 Scolopendra Species 0.000 claims description 9
- 241000522620 Scorpio Species 0.000 claims description 9
- 239000009490 scorpio Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000012567 medical material Substances 0.000 claims description 5
- 238000007598 dipping method Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000011265 semifinished product Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 43
- 229940079593 drug Drugs 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 24
- 210000003734 kidney Anatomy 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000002193 Pain Diseases 0.000 abstract description 11
- 230000007812 deficiency Effects 0.000 abstract description 10
- 231100000862 numbness Toxicity 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241000257303 Hymenoptera Species 0.000 abstract description 3
- 208000008765 Sciatica Diseases 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 3
- 206010005963 Bone formation increased Diseases 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 206010033799 Paralysis Diseases 0.000 abstract 2
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 210000003127 knee Anatomy 0.000 abstract 1
- 241001509962 Coptotermes formosanus Species 0.000 description 7
- 208000004044 Hypesthesia Diseases 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 208000034783 hypoesthesia Diseases 0.000 description 7
- 210000000629 knee joint Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000019802 Sexually transmitted disease Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 201000003068 rheumatic fever Diseases 0.000 description 6
- 238000005303 weighing Methods 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 238000009534 blood test Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000021251 pulses Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 2
- 206010002942 Apathy Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000009435 building construction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 210000004303 peritoneum Anatomy 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- TZFWDZFKRBELIQ-UHFFFAOYSA-N chlorzoxazone Chemical compound ClC1=CC=C2OC(O)=NC2=C1 TZFWDZFKRBELIQ-UHFFFAOYSA-N 0.000 description 1
- 229960003633 chlorzoxazone Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- -1 filtration Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
药材名称 | 饮片重量 | 粉碎后得粉重 | 过100目筛后得粉量 | 细粉率% |
威灵仙 | 7kg | 6.8kg | 6.58kg | 94 |
人参 | 700g | 650g | 610g | 87.1 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100127206A CN1234401C (zh) | 2004-02-10 | 2004-02-10 | 双蚁祛湿通络胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100127206A CN1234401C (zh) | 2004-02-10 | 2004-02-10 | 双蚁祛湿通络胶囊 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1557383A CN1557383A (zh) | 2004-12-29 |
CN1234401C true CN1234401C (zh) | 2006-01-04 |
Family
ID=34351054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100127206A Expired - Lifetime CN1234401C (zh) | 2004-02-10 | 2004-02-10 | 双蚁祛湿通络胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1234401C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1958052B (zh) * | 2005-11-04 | 2010-05-12 | 郭炳云 | 一种治疗类风湿性关节炎、强直性脊柱炎的药物 |
CN102048161B (zh) * | 2009-10-28 | 2013-04-17 | 江西三琦药业有限公司 | 一种以白蚁为主要原料制成的提高人体免疫力的保健食品 |
CN102370162B (zh) * | 2010-08-07 | 2013-03-27 | 江西三琦药业有限公司 | 一种以白蚁为主要原料制成的缓解体力疲劳的保健食品 |
CN103566236B (zh) * | 2013-11-08 | 2015-08-19 | 广西双蚁药业有限公司 | 一种祛湿通络中药制剂 |
CN103599425A (zh) * | 2013-11-08 | 2014-02-26 | 广西双蚁药业有限公司 | 新型双蚁祛湿通络胶囊 |
CN104667044A (zh) * | 2015-02-15 | 2015-06-03 | 广西双蚁药业有限公司 | 一种治疗痹症的中药制剂及其制备方法 |
CN104984162A (zh) * | 2015-06-30 | 2015-10-21 | 天峨县平昌生态农业有限公司 | 一种具有祛湿通络功效的中药制剂 |
-
2004
- 2004-02-10 CN CNB2004100127206A patent/CN1234401C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1557383A (zh) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102038758B (zh) | 治疗风湿病的风湿病制剂 | |
CN101810685A (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
CN103768567A (zh) | 一种黑膏药及其制备方法 | |
CN102772704A (zh) | 老年病药物 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN103301267B (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
CN103990079A (zh) | 用于治疗气滞血瘀型腰肌劳损的药物组合物及其制备方法 | |
CN1234401C (zh) | 双蚁祛湿通络胶囊 | |
CN103405582A (zh) | 改善类风湿关节炎关节肿痛的中药组合物 | |
CN102847061B (zh) | 一种治疗小儿病毒性心肌炎的中药制剂及其制备方法 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN103736017A (zh) | 一种治疗肋间神经痛的中药组合物及其制备方法 | |
CN102145127A (zh) | 一种治疗类风湿关节炎的药物及其制备方法 | |
CN102178866B (zh) | 用于气郁、血瘀体质人袪湿活血、软坚散结的中药制剂及其制备方法和应用 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN102935156B (zh) | 一种治疗骨质增生症的丸剂 | |
CN101708230B (zh) | 一种戒毒的药物及其制备方法 | |
CN105267711A (zh) | 一种用于治疗眩晕症的药物制剂 | |
CN100352489C (zh) | 治疗类风湿关节炎犬骨复方药剂 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN103432418B (zh) | 一种痛风止痛的中药组合物及其制备方法和用途 | |
CN103690771B (zh) | 用于治疗羔羊大肠杆菌病的药物及其制备方法 | |
CN106344680A (zh) | 一种具有祛风痛痹作用的中药组合物及其制备方法 | |
CN104547695B (zh) | 一种用于治疗三叉神经痛的药物组合物及其应用 | |
CN104173808B (zh) | 一种治疗肝火上炎型高血压的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: GUANGXI SHUANGYI PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: GUANGXI LAIBIN JINQIANCAO PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 546100 guest house, 388 Xin Lu, the Guangxi Zhuang Autonomous Region Patentee after: GUANGXI DOUBLE ANT PHARMACEUTICAL Co.,Ltd. Address before: 546100 the Guangxi Zhuang Autonomous Region guest 258 north two road Patentee before: Guangxi Laibin Jinqian Herbal Medicine Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Shuangyi Qushi Tongluo Capsule Effective date of registration: 20201010 Granted publication date: 20060104 Pledgee: Guangxi Laibin Guizhong Rural Cooperative Bank Pledgor: GUANGXI DOUBLE ANT PHARMACEUTICAL Co.,Ltd. Registration number: Y2020450000041 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220805 Granted publication date: 20060104 Pledgee: Guangxi Laibin Guizhong Rural Cooperative Bank Pledgor: GUANGXI DOUBLE ANT PHARMACEUTICAL Co.,Ltd. Registration number: Y2020450000041 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Shuangyi Qushi Tongluo Capsules Effective date of registration: 20220905 Granted publication date: 20060104 Pledgee: Guangxi Laibin Rural Commercial Bank Co.,Ltd. Pledgor: GUANGXI DOUBLE ANT PHARMACEUTICAL Co.,Ltd. Registration number: Y2022450000147 |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060104 |